Manuscripts

Search by keyword or author name.

Showing 1453 manuscripts.

Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age

J C Lindsey, D L Jacobson, H Spiegel, C M Gordon, R Hazra, G K Siberry, IMPAACT P1076 Study Team. Safety and efficacy of 48 and 96 weeks of alendronate in children and adolescents with perinatal HIV infection and low bone mineral density for age. Clinical Infectious Diseases. 2021. PMID: 32584996

Journal

Clinical Infectious Diseases

Study

P1076

Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV

Debika Bhattacharya, Rong Guo, Chi-Hong Tseng, Lynda Emel, Ren Sun, Shih-Hsin Chiu, Lynda Stranix-Chibanda, Tsungai Chipato, Neaka Mohtashemi, Kenneth Kintu, Karim Manji, Dhayendre Moodley, Chloe Thio, Yvonne Maldonado, Judith Currier. Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBV. Pediaric Infectious Disease Journal. 2021. PMID: 33181788

Journal

Pediaric Infectious Disease Journal

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

Theodore Ruel, Edmund Capparelli, Camlin Tierney, Bryan Nelson, Anne Coletti, Yvonne Bryson, Mark Cotton, Stephen Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen Chadwick. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study. Lancet HIV. 2021. PMID: 33242457

Journal

Lancet HIV

Study

P1115